No biomarker	Renal Cell Carcinoma	No biomarker	Renal Cell Carcinoma	ALLO-316 Sensitive: B - Late Trials ALLO-316 Sensitive : B	ALLO-316 Sensitive: B - Late Trials ALLO-316 Sensitive : B
CD70 expression	Acute Myelogenous Leukemia	CD70 expression	Acute Myelogenous Leukemia	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D
CD70 expression	Renal Cell Carcinoma	CD70 expression	Renal Cell Carcinoma	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D
CD70 expression	B Acute Lymphoblastic Leukemia	CD70 expression	B Acute Lymphoblastic Leukemia	CD70-targeted CAR-T immunotherapy Sensitive: D – Preclinical CD70-targeted CAR-T immunotherapy Sensitive : D	CD70-targeted CAR-T immunotherapy Sensitive: D – Preclinical CD70-targeted CAR-T immunotherapy Sensitive : D

CD70-targeted CAR-T immunotherapy

Associations(4)